New Updates in Drug Formulation & Bioavailability 2026

Positive trend for Swedish medtech exports – “We have new markets that are huge”

In 2024, Swedish exports of pharmaceuticals decreased for the first time in several years. However, the trend for medical technology looks brighter. During a se...

Meet us at Control 2025

Innovations that drive efficiency.

AstraZeneca´s Trixeo approved in the UK using propellant with near-zero Global Warming Potential

AstraZeneca has received approval in the United Kingdom for its inhaled respiratory medicine Trixeo Aerosphere with a new propellant that is reported to reduce ...

Merck KGaA acquires American company in €3.0 billion deal

Germany’s Merck is completing the acquisition of Springwork Therapeutics for 3 billion euros.

Positivt USA-besked om Alzecures smärtpreparat

Alzecure har beviljats särläkemedelsstatus i USA för smärtpreparatet ACD440.

ZEISS Lightfield 4D for instant volumetric high-speed imaging

Capturing physiological and neuronal processes in 3D.

New Horizons in Biologics & Bioprocessing: Copenhagen 2026

Dödsstraff yrkas för mordet på amerikansk vård-vd

Åklagarsidan kommer att yrka på dödsstraff för Luigi Mangione, som står inför rätta för mordet på sjukvårdsförsäkringsbolaget United Healths vd Brian Thompson i New York i fjol....

CT technology for when the inside matters

ZEISS METROTOM 1 now at #HandsOnMetrology.

Cost-efficient development of laboratory devices

8 ways to optimise development costs and speed up processes

Cancer researcher: “We can do better and reduce suffering”

Lund University researcher Catharina Hagerling is developing innovative methods to understand metastatic cancer, aiming to create more targeted treatments for p...

FDA godkänner Gileads injektion mot hiv: ”Avgörande ögonblick”

Gilead Sciences förbyggande hiv-läkemedel lenakapavir godkändes på onsdagen av den amerikanska läkemedelsmyndigheten FDA. Nu tänds hoppet om att äntligen kunna ...

Alvotech i nytt miljardavtal om biosimilarer

Stockholmsnoterade Alvotech har ingått avtal med brittiska Advanz Pharma om kommersialisering av tre biosimilarkandidater.

Snabbtest ska hitta rätt behandling mot giftormens bett

Var sjätte sekund råkar någon på vår jord ut för ett ormbett, och varje gång startar en jakt mot klockan. Vad var det för orm som bet, och vilket motgift kan hj...

ZEISS Quality Innovations at CONTROL

May 6-9, 2025 in Stuttgart.

A new giant among our microscopes

Two technologies in one machine.

FDA plans to replace animal testing with AI – “Paradigm shift”

The requirement for animal testing in drug development will be phased out and replaced by AI, according to an announcement by the FDA. The decision has been met...

Björn Arvidsson will lead research and innovation in Region Uppsala

The Swedish life science profile Björn Arvidsson has been appointed Director of Research and Innovation for Region Uppsala.

We desire talent to come here, but are we genuinely welcoming them?

Sweden faces significant challenges in creating a truly inclusive environment that makes international professionals feel welcome, valued, and able to build mea...

Avhopp i Kennedys vaccinkommitté inför första mötet

Efter att ha sparkat samtliga experter i USA:s vaccinkommitté och tillsatt åtta nya, står hälsominister Robert F. Kennedy Jr. nu med en ofullständig panel. En m...

Veteranen inom läkemedelsformulering: Mycket aktivitet i fältet

Korbinian Löbmann har flera gånger tidigare modererat New Updates in Drug Formulation & Bioavailability. Nu tar han åter sig an det vetenskapliga mötet.

Quality assurance for research and development of medical devices

Overcome the hurdles of research, development, and QA lab environments within the regulated medical technology industry.

ZEISS receives FDA clearance for INTRABEAM 700

With its new treatment platform for intraoperative radiotherapy, ZEISS is actively shaping the medical innovation of neuro tumor therapy.